Now showing items 1-12 of 12
| Title | Author(s) | Journal | Issue Date | Type |
|---|---|---|---|---|
| Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia | Denison, J. A.; Koole, O.; Tsui, S.; Menten, J.; Torpey, K.; Van Praag, E.; Mukadi, Y. D.; Colebunders, R.; Auld, A. F.; Agolory, S.; Kaplan, J.; Mulenga, M.; Kwesigabo, G.; Wabwire-Mangen, F.; Bangsberg, D. R. | AIDS | 2015 | Article |
| Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia | van Griensven, J.; Phirum, L.; Choun, K.; Thai, S.; De Weggheleire, A.; Lynen, L. | PLoS ONE | 2014 | Article-E |
| Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa | Okomo, U.; Togun, T.; Oko, F.; Peterson, K.; Townend, J.; Peterson, I.; Jaye, A. | BMC Pediatrics | 2012 | Article-E |
| Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin | Lamorde, M.; Byakika-Kibwika, P.; Okaba-Kayom, V.; Ryan, M.; Coakley, P.; Boffito, M.; Namakula, R.; Kalemeera, F.; Colebunders, R.; Back, D.; Khoo, S.; Merry, C. | Journal of Antimicrobial Chemotherapy | 2011 | Article |
| Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor containing regimen | Conesa-Botella, A.; Florence, E.; Lynen, L.; Colebunders, R.; Menten, J.; Moreno-Reyes, R. | AIDS Research and Therapy | 2010 | Article-E |
| Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda | Ocama, P.; Castelnuovo, B.; Kamya, M. R.; Kirk, G. D.; Reynolds, S. J.; Kiragga, A.; Colebunders, R.; Thomas, D. L. | International Journal of STD & AIDS | 2010 | Article |
| Reducing pediatric HIV infection: estimating mother to child transmission rates in a program setting in Zambia | Torpey, K.; Kasonde, P.; Kabaso, M.; Weaver, M. A.; Bryan, G.; Mukonka, V.; Bweupe, M.; Zimba, C.; Mwale, F.; Colebunders, R. | Journal of Acquired Immune Deficiency Syndromes | 2010 | Article |
| Substituting nevirapine for efavirenz: risk factors for toxicity in nonnaive patients in a resource-constrained setting [correspondence] | van Griensven, J.; Un, P.; Phe, T.; Thai, S.; Lynen, L. | AIDS | 2009 | Letter |
| Extensive hypopigmentation after starting antiretroviral treatment in an human immunodeficiency virus (hiv)-seropositive African woman [letter] | Kigonya, C.; Lutwama, F.; Colebunders, R. | International Journal of Dermatology | 2008 | Letter |
| First-line antiretroviral therapy in Africa; how evidence-based are our recommendations? | Colebunders, R.; Kamya, M. R.; Laurence, J.; Kambugu, A.; Byakwaga, H.; Songa Mwebaze, P.; Muganzi Muganga, A.; Katwere, M.; Katabira, E.; Muganzi, A. | AIDS Reviews | 2005 | Article |
| Neuropsychiatric reaction induced by clarithromycin [letter] | Colebunders, R.; Florence, E. | Sexually Transmitted Infections | 2002 | Letter |
| Prevention of nevirapine-associated rash [letter] | Colebunders, R.; Schrooten, W.; Desmet, P.; De Roo, A.; Dreezen, C. | Lancet | 2001 | Letter |
Now showing items 1-12 of 12